We used a comprehensive multi-omics approach in which we quantified the metabolome, proteome and transcriptome of a large cohort of primary human AML patient samples and compared those to healthy CD34+ hematopoietic stem/progenitor cells. Here, CD34 is linked to acute myeloid leukemia.